Literature DB >> 11081107

Evaluation of a rapid test for HIV antibodies in saliva and blood.

L M Webber1, C Swanevelder, W O Grabow, P B Fourie.   

Abstract

OBJECTIVE: To test whole blood and saliva for HIV antibodies (anti-HIV) using a rapid test strip capillary flow immunoassay, and to correlate the test strip results with blood specimen results obtained from routine diagnostic anti-HIV assays.
DESIGN: A prospective pilot study of selected HIV-positive and HIV-negative individuals, children and medico-legal cases from Gauteng, South Africa.
METHODS: Whole blood specimens taken from every individual and medico-legal case (total study population 153) and saliva specimens taken from 76 selected cases were tested for anti-HIV using the respective Hema-Strip HIV-1/2, Sero-Strip HIV-1/2 and Saliva-Strip HIV-1/2 (Saliva Diagnostic Systems Inc.) rapid test strip methodology. All results were correlated with the currently recommended anti-HIV assays.
RESULTS: The whole blood test strip results correlated 100% with the traditional diagnostic results. Only two saliva test strip results tested false-negative, both from marasmic and severely dehydrated babies, while the other results were in concordance. All test strip results on postmortem blood and saliva were fully concordant with the diagnostic assay results.
CONCLUSION: The anti-HIV test strip methodology for whole blood and saliva specimens is rapid, reliable and easy to perform and interpret. Saliva specimens can be readily collected from any individual, and there is a reduction in hazard risk. Anti-HIV saliva testing using the test strip methodology is recommended for South Africa, particularly in high-risk situations such as the paediatric and forensic medicine settings. A large field study obtaining specimens from different regions in South Africa is advised.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11081107

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

1.  Use of rapid and conventional testing technologies for human immunodeficiency virus type 1 serologic screening in a rural Kenyan reference laboratory.

Authors:  Ginamarie Foglia; G Donald Royster; K Monique Wasunna; Rukia Kibaya; Jennifer A Malia; Eva K Calero; Warren Sateren; Philip O Renzullo; Merlin L Robb; Deborah L Birx; Nelson L Michael
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study.

Authors:  Ted Cohen; Megan Murray; Kristina Wallengren; Gonzalo G Alvarez; Elizabeth Y Samuel; Douglas Wilson
Journal:  PLoS Med       Date:  2010-06-22       Impact factor: 11.069

3.  Pathogenesis of oral FIV infection.

Authors:  Craig Miller; Karen Boegler; Scott Carver; Martha MacMillan; Helle Bielefeldt-Ohmann; Sue VandeWoude
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

4.  Factors associated with willingness to accept oral fluid HIV rapid testing among most-at-risk populations in China.

Authors:  Huanmiao Xun; Dianmin Kang; Tao Huang; Yuesheng Qian; Xiufang Li; Erin C Wilson; Shan Yang; Zhenxia Jiang; Cuihua Gong; Xiaorun Tao; Xijiang Zhang; Guoyong Wang; Yapei Song; Zhijian Xu; Gifty Marley; Pengcheng Huai; Wei Ma
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.